OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, today announced that Kenneth A. Adach will be appointed as the Company’s Vice President, Consumer Marketing.
Mr. Adach joins OraSure with extensive experience in consumer sales and marketing, including over twenty-five years of relevant over-the-counter (“OTC”) marketing experience. Since 2005, Mr. Adach has served as Director of Marketing for Bausch & Lomb’s highly successful line of OTC pharmaceutical products. From 1989 to 2005, Mr. Adach held senior marketing positions at Playtex Products, Inc., serving as Director of Marketing for feminine care and infant feeding products, and at Lehn & Fink, where he had marketing responsibility for the Minwax line of paints and stains. Earlier in his career, Mr. Adach served in various marketing positions at Unilever and the Lipton Tea Company. Mr. Adach received an MBA degree from Rutgers University and a B.S. degree in Marketing from the University of South Carolina.
“We are extremely pleased that Kenn has agreed to join OraSure and head up our consumer marketing efforts,” said Douglas A. Michels, President and CEO of OraSure Technologies. “We continue to make good progress in the clinical studies that will support our application for FDA approval of our OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test for use in the United States OTC market. Kenn’s primary responsibility will be to lead the effort to commercialize this product once FDA approval is obtained. With his consumer marketing background, we expect Kenn to be a valuable contributor for the Company.”
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pa., the company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. For more information on the Company, please go to www.orasure.com.
Contacts:
Ronald H. Spair
Chief Financial
Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com
